Raymond James Financial Inc Cue Biopharma, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 3,350 shares of CUE stock, worth $2,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,350Holding current value
$2,378% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CUE
# of Institutions
48Shares Held
17.7MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.84 Million1.47% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.37 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$2.26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$537,2820.0% of portfolio
-
Geode Capital Management, LLC Boston, MA692KShares$491,4420.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $25.1M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...